These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26904699)

  • 61. Analysis of the incidence of tumor lysis syndrome in patients with hematological malignancies treated with rasburicase.
    Usami E; Kimura M; Iwai M; Teramachi H; Yoshimura T
    Mol Clin Oncol; 2017 Jun; 6(6):955-959. PubMed ID: 28588796
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tumor Lysis Syndrome Rare Presentation As Uremic Pericarditis: A Case Report.
    Caleça Emidio F; Pereira R; Martins Dos Santos P; Abegão T
    Cureus; 2023 Mar; 15(3):e35727. PubMed ID: 36875257
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tumor lysis syndrome.
    Jeha S
    Semin Hematol; 2001 Oct; 38(4 Suppl 10):4-8. PubMed ID: 11694945
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clarifying the role of rasburicase in tumor lysis syndrome.
    Sood AR; Burry LD; Cheng DK
    Pharmacotherapy; 2007 Jan; 27(1):111-21. PubMed ID: 17192165
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rasburicase-Induced Methemoglobinemia in a Patient with Aggressive Non-Hodgkin's Lymphoma.
    Alessa MA; Craig AK; Cunningham JM
    Am J Case Rep; 2015 Sep; 16():590-3. PubMed ID: 26334783
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002.
    Navolanic PM; Pui CH; Larson RA; Bishop MR; Pearce TE; Cairo MS; Goldman SC; Jeha SC; Shanholtz CB; Leonard JP; McCubrey JA
    Leukemia; 2003 Mar; 17(3):499-514. PubMed ID: 12646938
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Management of tumor lysis syndrome in adults.
    Coiffier B; Riouffol C
    Expert Rev Anticancer Ther; 2007 Feb; 7(2):233-9. PubMed ID: 17288532
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Concurrent acute spontaneous tumor lysis syndrome complicated with multiple organ failure in a patient with pre-existing undiagnosed lung cancer.
    Amiri FS
    CEN Case Rep; 2015 Nov; 4(2):233-237. PubMed ID: 28509107
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A rare case of spontaneous tumor lysis syndrome in multiple myeloma.
    Aldabain L; Camire L; Weisman DS
    J Community Hosp Intern Med Perspect; 2020 Aug; 10(4):365-368. PubMed ID: 32850100
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Management of hyperuricemia with rasburicase review.
    de Bont JM; Pieters R
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1431-40. PubMed ID: 15571272
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tumour lysis syndrome in children: experience of last decade.
    Ahn YH; Kang HJ; Shin HY; Ahn HS; Choi Y; Kang HG
    Hematol Oncol; 2011 Dec; 29(4):196-201. PubMed ID: 21710502
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Spontaneous Tumor Lysis Syndrome: A Rare Presentation in Plasmablastic Lymphoma.
    Infante J; Casado A; Almeida A; Messias A
    J Hematol; 2021 Feb; 10(1):30-34. PubMed ID: 33643508
    [TBL] [Abstract][Full Text] [Related]  

  • 73. You Can't Always Blame the Chemo: A Rare Case of Spontaneous Tumor Lysis Syndrome in a Patient with Invasive Ductal Cell Carcinoma of the Breast.
    Parsi M; Rai M; Clay C
    Cureus; 2019 Nov; 11(11):e6186. PubMed ID: 31890391
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study.
    Coiffier B; Mounier N; Bologna S; Fermé C; Tilly H; Sonet A; Christian B; Casasnovas O; Jourdan E; Belhadj K; Herbrecht R;
    J Clin Oncol; 2003 Dec; 21(23):4402-6. PubMed ID: 14581437
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Spontaneous Tumor Lysis Syndrome in T-Cell Leukemia.
    Faheem B; Kollimuttathuillam S; Ashkar H; Maroules M
    Cureus; 2020 Oct; 12(10):e11002. PubMed ID: 33209558
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Acute spontaneous tumor lysis presenting with hyperuricemic acute renal failure: clinical features and therapeutic approach.
    Hsu HH; Chan YL; Huang CC
    J Nephrol; 2004; 17(1):50-6. PubMed ID: 15151259
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment-naïve spontaneous tumor lysis syndrome in metastatic prostate adenocarcinoma: An unusual suspect.
    Ignaszewski M; Kohlitz P
    Am J Emerg Med; 2017 Sep; 35(9):1384.e1-1384.e2. PubMed ID: 28587951
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Economic implications of rasburicase treatment in adult patients with tumour lysis syndrome.
    Eaddy M; Seal B; Tangirala K; Davies EH; O'Day K
    Appl Health Econ Health Policy; 2012 Nov; 10(6):431-40. PubMed ID: 23013428
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Spontaneous Tumour Lysis Syndrome in a Multiple Myeloma.
    Huzmeli C; Eliacik E; Saglam M; Doner B; Candan F
    Case Rep Med; 2016; 2016():9620520. PubMed ID: 27956901
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Tumor lysis syndrome, acute kidney injury and disease-free survival in critically ill patients requiring urgent chemotherapy.
    Abdel-Nabey M; Chaba A; Serre J; Lengliné E; Azoulay E; Darmon M; Zafrani L
    Ann Intensive Care; 2022 Feb; 12(1):15. PubMed ID: 35166948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.